preeclampsia - Nursing Case Study

Pathophysiology

• Primary mechanism: Abnormal placentation leads to inadequate remodeling of spiral arteries, causing high resistance and reduced blood flow to the placenta, triggering systemic endothelial dysfunction.

• Secondary mechanism: Endothelial dysfunction increases the release of vasoconstrictors and reduces vasodilators, resulting in hypertension and decreased perfusion to maternal organs.

• Key complication: End-organ damage, particularly in the kidneys and liver, can occur due to persistent hypertension and compromised blood flow, increasing the risk of maternal and fetal morbidity.

Patient Profile

Demographics:

28-year-old female, teacher

History:

• Key past medical history: Gestational diabetes in previous pregnancy

• Current medications: Prenatal vitamins, low-dose aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headache and visual disturbances

• Key symptoms: Swelling in hands and feet, upper abdominal pain, nausea

• Vital signs: Blood pressure 160/100 mmHg, heart rate 90 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team decided to conduct further diagnostic tests to better understand the extent of the preeclampsia and its impact on the patient. Laboratory results revealed elevated liver enzymes (AST 90 U/L, ALT 95 U/L), indicating potential hepatic involvement, and proteinuria with a urine protein-to-creatinine ratio of 0.4, confirming significant renal impairment. These findings corroborate the concern for end-organ damage, aligning with the patient's persistent hypertension and symptoms of upper abdominal pain and nausea.

Ultrasound imaging of the fetus was performed to assess fetal well-being and placental function, revealing decreased amniotic fluid levels (oligohydramnios) and signs of fetal growth restriction, suggesting compromised placental perfusion. The Doppler studies of the umbilical artery indicated increased resistance, further supporting the diagnosis of impaired placental blood flow. These results underscore the need for close monitoring of both maternal and fetal health and provide critical data for determining the appropriate timing and method of delivery to minimize risks.

The new diagnostic results highlight the growing complexity of the patient's condition, necessitating a multidisciplinary approach to care. The healthcare team must prioritize maternal stabilization while considering potential interventions to optimize fetal outcomes. This situation requires careful clinical reasoning to weigh the risks and benefits of potential treatments, such as magnesium sulfate for seizure prophylaxis and corticosteroids to enhance fetal lung maturity, as the team prepares for possible preterm delivery. The evolving clinical picture demands vigilant monitoring and timely intervention to address any further complications that may arise.

Section 2

As the healthcare team continues to monitor the patient, a change in her status becomes evident. Her blood pressure, previously managed with antihypertensive medication, has begun to escalate, now reading 165/105 mmHg. Accompanying this change, the patient reports a worsening of her upper abdominal pain, which is now more constant and severe. She also exhibits mild confusion and has developed a headache that is unresponsive to analgesics. These symptoms raise concern for the potential progression to severe preeclampsia or even HELLP syndrome, necessitating prompt evaluation and intervention.

In response to these developments, the healthcare team re-evaluates the treatment plan, prioritizing stabilization of the mother's condition. Given the elevated blood pressure and neurological symptoms, the decision is made to initiate magnesium sulfate therapy to prevent eclampsia. Additionally, a repeat complete blood count and liver function tests are ordered, revealing a further increase in liver enzymes (AST 120 U/L, ALT 110 U/L) and a drop in platelet count to 110,000/mm³, which further supports the suspicion of evolving HELLP syndrome.

This change in the patient's status prompts an urgent interdisciplinary meeting to discuss the timing of delivery. The team weighs the maternal risks against the potential benefits of prolonging the pregnancy for fetal maturity. Since the fetus is exhibiting signs of distress with confirmed oligohydramnios and growth restriction, the consensus leans towards expediting delivery. Corticosteroids have already been administered to promote fetal lung maturity, and preparations are made for potential cesarean section if the patient's condition does not stabilize rapidly. This course of action underscores the critical need for vigilant monitoring and readiness to adapt to the changing clinical picture, ensuring the best possible outcomes for both mother and child.

Section 3

In the hours following the initiation of magnesium sulfate therapy, the healthcare team remains vigilant in assessing the patient’s response to the intervention. The nurse on duty reports that the patient’s deep tendon reflexes are slightly diminished, and she begins to exhibit signs of respiratory depression, with a respiratory rate dropping to 10 breaths per minute. These findings raise immediate concern for magnesium toxicity, prompting the administration of calcium gluconate as an antidote to counteract the effects. Concurrently, the blood pressure remains elevated at 160/100 mmHg despite adjustments in antihypertensive medication, indicating persistent instability.

Laboratory results processed shortly thereafter reveal a further decline in platelet count to 95,000/mm³ and liver enzymes continuing to rise, with AST at 135 U/L and ALT at 125 U/L. These results confirm the progression of HELLP syndrome, necessitating an urgent revision of the management plan. The fetus, under continuous electronic fetal monitoring, shows recurrent late decelerations, suggesting increasing fetal compromise. In light of these developments, the team decides to proceed with an emergency cesarean section to address both maternal and fetal risks.

As preparations for surgery begin, the patient’s condition remains a top priority. The anesthesiology team is briefed on her current status, particularly the potential for coagulopathy due to thrombocytopenia, which could complicate regional anesthesia. Continuous communication ensures that all team members are aligned in their understanding and approach. The decision to expedite delivery underscores the critical intersection of maternal and fetal medicine, as the team works to swiftly adapt to the evolving challenges and ensure the safest possible outcome for both mother and child.

Section 4

As the surgical team prepares for the emergency cesarean section, the nurse performs an initial assessment to update on the patient’s current status. The patient is alert but appears fatigued and anxious. Her skin is noted to be cool and clammy, with a capillary refill time of over 3 seconds, suggesting potential circulatory compromise. Auscultation reveals diminished breath sounds bilaterally, aligning with the earlier signs of respiratory depression. The patient's blood pressure is recorded at 165/105 mmHg, and heart rate has increased to 110 beats per minute, possibly indicating a compensatory response to the stress of ongoing complications.

The obstetrician also reviews the latest fetal monitoring strip. The late decelerations have become more pronounced, with decreased variability in the fetal heart rate, underscoring the urgency of the situation. The team discusses the implications of these findings, recognizing the increased risk of fetal hypoxia. The decision to proceed with general anesthesia is made, given the patient's thrombocytopenia and potential bleeding risks associated with regional anesthesia.

As the patient is transported to the operating room, the interdisciplinary team reassesses their roles and ensures that all necessary equipment and medications, including those for potential neonatal resuscitation, are readily available. The anesthesiology team prepares for rapid sequence induction, understanding the delicate balance required to manage the patient's respiratory status while avoiding further hemodynamic instability. This coordinated approach exemplifies the critical nature of teamwork and communication in managing complex cases such as this, as every moment counts to ensure the best possible outcomes for both mother and baby.

Section 5

As the surgical team proceeds with the emergency cesarean section, the nurse closely monitors the patient's hemodynamic status. The anesthesiology team successfully completes the rapid sequence induction, and the patient is now under general anesthesia. However, as the surgery begins, the nurse notes a significant drop in the patient's blood pressure, recorded at 90/60 mmHg. This abrupt change indicates potential hypovolemia or the onset of shock, requiring immediate intervention. The anesthesiologist administers intravenous fluids and vasopressors to stabilize the patient's blood pressure while continuously monitoring her heart rate, which has further increased to 120 beats per minute.

Simultaneously, the obstetrics team encounters unexpected complications. Upon delivery, the newborn exhibits signs of distress, with a weak cry and poor muscle tone. The neonatal team swiftly initiates resuscitation efforts, providing positive pressure ventilation and supplemental oxygen. In the meantime, the nurse observes that the patient's uterus is atonic, failing to contract adequately, leading to increased bleeding. Uterotonic agents are administered to enhance uterine contraction and control hemorrhage, while the surgical team works efficiently to manage blood loss.

As the scenario unfolds, the team reflects on the interconnected nature of the complications arising from preeclampsia. The patient's initial signs of circulatory compromise and respiratory depression have cascaded into both maternal and neonatal challenges, underscoring the critical need for ongoing assessment and rapid response. The coordinated efforts of the interdisciplinary team highlight the importance of vigilance in monitoring changes in vital signs and laboratory values, guiding clinical reasoning and decision-making during this high-stakes situation. With the timely intervention, the patient begins to stabilize, and the neonatal team notes improvement in the newborn's condition, allowing for a cautious sense of optimism as both mother and child are transferred to the recovery unit for further observation and care.